| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Websense Web Filtering - Good or Bad? |
|
Advice You - Websense Web Filtering - Good or Bad?
Companies like Websense sell their web filtering software to corporate clients. Their marketing material is pointing o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ut how much productivity is lost due to employees casually surfing the web while at work. With Websense software corpo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rations are able to restrict web surfing to certain websites and put monitoring in place. This allows to protect the c lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. orporations from malicious viruses entering the network from untrusted websites and to limit the overall Internet acti here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe vity of employees to business related websites. It also allows to run specific reporting on every user and to monitor d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro web usage on a per user base. But how much web monitoring and filtering is really helping a corporation and when is f ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc iltering getting too tight? Everyone agrees - an employee is paid a certain amount of money in return for his or her w easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ork. An employee should not be paid for surfing the web. Websense can also be useful protecting the network environmen nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t from Trojans and viruses. But a tool like Websense does not really make a difference between the employee taking a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ quick break after a very hectic morning and between the lazy employee surfing the web 5 hours a day. Everyone is monit ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ored and all activity is logged. The danger with a tool like Websense is: who is running the reports and how are these ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a reports used. The 5 hour a day employee web surfer does need to be fired - no doubt. But does the occasionally web su dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rfing employee gets into trouble when surfing the web on a slow day with not enough work to fill the hours? There migh cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t be the sudden 1.5 hours of web surfing going on. Or how about the IT admin doing research on the Internet?! He might tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen spend hours on the Internet researching problems. That can be part of his job. If the person looking at the reports d t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel oes not look behind the report and just judges the user based on the time spend on the web or how much bandwidth he/sh ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e has used, wrong accusations can be made. Websense is also not foolproof and if a session to website is open it count y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products s the web usage - even if the user only minimized the browser window to continue working. This can be misleading. The . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de re is much more to Websense than just filtering and logging and monitoring. To successfully use Websense a corporation elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip also needs to spend the time to do research on the results. Just by judging a user based on the reports is not enough tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Selling Your Business - What Would Sam Zell Do? S Corp or LLC? That is the Question
|